Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam goal-directed intraoperative sedation for postoperative sleep quality in elderly arthroplasty patients
ChiCTR2000041286Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in sleep disorder (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Sleep quality on the postoperative night. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2000041286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041286.